Use of enteral nutrition for stress ulcer prophylaxis.
OBJECTIVE
To review the controversies involving the use of enteral nutrition support for stress ulcer prophylaxis and formulate recommendations.


METHODS
A MEDLINE search (1966-December 2000) was conducted using the MeSH of nutrition, ulcer, critical care, and acid to identify relevant articles. References of selected articles were reviewed, and relevant abstracts from critical care or gastrointestinal journals identified.


METHODS
Animal and human data from prospective studies, retrospective studies, and case series were evaluated for the effects of enteral nutrition on gastric pH, intramucosal pH, gastrointestinal blood flow, development of macroscopic mucosal erosions, and hemorrhage.


RESULTS
Intragastric administration of enteral nutrition has variable effects on gastric pH, enhances regional distribution of gastrointestinal blood flow, and may lower intramucosal pH. All substrates (carbohydrate, lipid, amino acid), when administered into the stomach, reduce the occurrence of mucosal erosions but do not entirely prevent their development. Few studies of stress ulcer prophylaxis regimens have reported use of enteral nutrition. Limited retrospective data suggest enteral nutrition support may be effective for preventing gastrointestinal hemorrhage, but the results of prospective studies are confounded by poor study design.


CONCLUSIONS
Definitive recommendations regarding the role of enteral nutrition for stress ulcer prophylaxis are not possible due to the lack of prospective, randomized studies. Therefore, the use of enteral nutrition as the only therapeutic agent for stress ulcer prophylaxis should be discouraged until definitive data are available. Initiation and discontinuation of pharmacologic stress ulcer prophylaxis should be independent of enteral nutrition.
MacLaren
R
R
School of Pharmacy, C238, University of Colorado Health Sciences Center, 4200 E. Ninth Ave., Denver, CO 80262-0001, USA. rob.maclaren@uchsc.edu
Jarvis
C L
CL
Fish
D N
DN
D000818:Animals; D000863:Antacids / Q000627:therapeutic use*; D003422:Critical Care; D004750:Enteral Nutrition; D006801:Humans; D006863:Hydrogen-Ion Concentration; D010437:Peptic Ulcer / Q000517:prevention & control / Q000628:therapy; D051381:Rats; D013315:Stress, Psychological
D000863:Antacids